EAST HILLS, N.Y., Dec. 2 -- Pall Corp. announced Tuesday it has completed the acquisition of the BioSepra Process Division from Ciphergen Biosystems Inc., of Fremont, Calif. The purchase price was $32 million, net of cash and debt. The BioSepra Process Division develops, manufactures and markets chromatography sorbents used in protein purification for drug development and production.
Pall and Ciphergen have also entered into a collaboration for process proteomics, based on the combination of Ciphergen's ProteinChip technology and BioSepra's chromatography products.
Pall makes filtration, separations and purification technology for life sciences and industrial markets, including biotechnology, pharmaceutical, transfusion medicine, semiconductor, water purification and aerospace applications.
For more information, visit: www.pall.com